Innovent Biologics’s stock leapt almost 20 percent on its listing in October, boosting hopes for the sector after the first few companies plunged below their IPO prices.
Shanghai Junshi Biosciences soars 21 percent on HK debut
More from Industry NewsMore posts in Industry News »
- FDA panel endorses booster shot for J&J Covid-19 vaccine
- Intas launches the World’s first SB-100mg Itraconazole
- Second J&J COVID-19 shot gets expert backing; FDA is looking at lowering age for Pfizer booster
- StayHappi pharmacy enters Assam with 70 stores
- Mumbai: Larger ITAT bench to rule on pharma freebies